Julie Daves
2023
In 2023, Julie Daves earned a total compensation of $533.4K as SVP, Clinical Development Operations at DiaMedica Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $91,657 |
|---|---|
| Option Awards | $118,309 |
| Salary | $306,754 |
| Other | $16,650 |
| Total | $533,370 |
Daves received $306.8K in salary, accounting for 58% of the total pay in 2023.
Daves also received $91.7K in non-equity incentive plan, $118.3K in option awards and $16.7K in other compensation.
Rankings
In 2023, Julie Daves' compensation ranked 1,956th out of 2,993 executives tracked by ExecPay. In other words, Daves earned more than 34.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,956 out of 2,993 | 35th |
Division Manufacturing | 1,118 out of 1,640 | 32nd |
Major group Chemicals And Allied Products | 690 out of 909 | 24th |
Industry group Drugs | 673 out of 872 | 23rd |
Industry Pharmaceutical Preparations | 483 out of 630 | 23rd |
Source: SEC filing on April 4, 2024.
Daves' colleagues
We found three more compensation records of executives who worked with Julie Daves at DiaMedica Therapeutics in 2023.